Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Ra Capital Management, L.P. reported a 9.90% stake in Taysha Gene Therapies, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Ra Capital Management, L.P. reported a 9.90% stake in Taysha Gene Therapies, Inc., 27,662,481 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 27,662,481
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 27,662,481 |
| Peter Kolchinsky | 9.90% | 27,662,481 |
| Rajeev Shah | 9.90% | 27,662,481 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 27,662,481 |
Source
Related
- Taysha Gene Therapies, Inc.
- Ra Capital Management, L.P.
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2025
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Stalfort John A III · Jun 2, 2026
- Form 4 · Donenberg Phillip B. · Jun 2, 2026
- Form 4 · Long Alison S · Jun 2, 2026